Original articlesHematologic malignanciesCentral nervous system relapse of diffuse large B-cell lymphoma in the rituximab era: results of the UK NCRI R-CHOP-14 versus 21 trial
Hematologic malignancies
Under a Creative Commons license
open access
diffuse large B-cell lymphoma
rituximab
central nervous system
relapse
Cited by (0)
Copyright © 2017 THE AUTHORS. Published by Elsevier Ltd.